Patent details

EP2298340 Title: Immunogenic composition for use in vaccination against staphylococcei.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2298340
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10010422.3
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Belgium (BE)
Publications:

Dates

Filing date:
20/09/2005
Grant date:
16/04/2014
EP Publication Date:
16/04/2014
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
16/04/2014
EP B1 Publication Date:
16/04/2014
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
28/05/2014
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
19/09/2025
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
16/04/2014
 
 

 

Name:
GlaxoSmithKline Biologicals S.A.
Address:
rue de l'Institut, 89, 1330 RIXENSART, Belgium (BE)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
16/04/2014
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Castado, Cindy
Address:
1330 RIXENSART, Belgium (BE)

2

Name:
Lecrenier, Nicolas Pierre Fernand
Address:
1330 RIXENSART, Belgium (BE)

3

Name:
Neyt, Cecile Anne
Address:
1330 RIXENSART, Belgium (BE)

4

Name:
Poolman, Jan
Address:
1330 RIXENSART, Belgium (BE)

Priority

1

Priority Patent Number:
0503143
Priority Date:
15/02/2005
Priority Country:
United Kingdom (GB)

2

Priority Patent Number:
0421079
Priority Date:
22/09/2004
Priority Country:
United Kingdom (GB)

3

Priority Patent Number:
0421081
Priority Date:
22/09/2004
Priority Country:
United Kingdom (GB)

4

Priority Patent Number:
0421078
Priority Date:
22/09/2004
Priority Country:
United Kingdom (GB)

5

Priority Patent Number:
0421082
Priority Date:
22/09/2004
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 39/085;
IPC or IDT classification:
A61K 39/116; A61P 31/04;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
2014/24
Publication date:
11/06/2014
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
2014/17
Publication date:
23/04/2014
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201416
Publication date:
16/04/2014
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
30/09/2024
Grace Period End Date:
31/03/2025
Annual Fee Number:
20
Annual Fee Amount:
1400 Euro
Penalty Fee Amount:
700 Euro
Last Annual Payment Date:
22/08/2023
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
1300 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
02/06/2014 Outgoing Correspondence Outgoing Letter 1 PDF /2/2/4/0/1/0510010422/docs/ep10010422.3_1_outgoingcorrespondence20140602.pdf
28/05/2014 Claims Translated claims 2 PDF /2/2/4/0/1/0510010422/docs/ep10010422.3_0_claims20140528.pdf
28/05/2014 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /2/2/4/0/1/0510010422/docs/ep10010422.3_2_incomingcorrespondencepaper20140528.pdf
28/05/2014 Outgoing Correspondence Outgoing Letter 1 PDF /2/2/4/0/1/0510010422/docs/ep10010422.3_3_outgoingcorrespondence20140528.pdf